Tambagel, Rhea Mae .
HRN: 22-48-00 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2023
CEFUROXIME 750MG (VIAL)
01/18/2023
01/25/2023
IV
750 Mg
Q8
UTI
Waiting Final Action